ÂÜÀòÂÒÂ×

Natalia Venetz is a Scientist specializing in oncology research at Molecular Partners AG in Zurich, Switzerland, since March 2019, with a focus on cancer immunotherapy. Prior to this role, Natalia served as a post-doctoral researcher at Universitat Hospital Zurich, working on the development of cytokine-based immunotherapies from February 2016 to February 2019. Earlier experience includes a position as a Senior Research Associate at Molecular Partners AG from 2008 to 2011, where the development and characterization of DARPins for inflammatory diseases and cancer were emphasized. Natalia's career also includes a research associate role in the Protein Engineering department at Genentech, where studies focused on protein biochemistry, and an internship in protein purification at Laboratoire de Chimie Bactérienne-CNRS. Academic qualifications include a PhD in Cancer Immunotherapy from the University of Zurich and an Ingénieur en Biotechnologie degree from Université de Provence.